| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699373 | Clinical Oncology | 2009 | 9 Pages |
Abstract
In this small cohort of patients with stage I peripheral NSCLC, robotic stereotactic radiotherapy seems to be a safe and obviously superior alternative to conventionally fractionated radiotherapy, with results that may be approaching those obtained with lobectomy without the associated morbidity.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
W.T. Brown, X. Wu, F. Fayad, J.F. Fowler, S. GarcÃa, M.I. Monterroso, A. de la Zerda, J.G. Schwade,